Correction: MED10 drives the oncogenicity and refractory phenotype of bladder urothelial carcinoma through the upregulation of hsa-miR-590 (Frontiers in Oncology, (2022), 11, (744937), 10.3389/fonc.2021.744937)

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

指紋

深入研究「Correction: MED10 drives the oncogenicity and refractory phenotype of bladder urothelial carcinoma through the upregulation of hsa-miR-590 (Frontiers in Oncology, (2022), 11, (744937), 10.3389/fonc.2021.744937)」主題。共同形成了獨特的指紋。

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions